You are viewing an incomplete version of our website. Please click to reload the website as full version.

CrmA Or CPXV207 Protein antibody

Details for Product No. ABIN967526, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Cowpox virus
Clonality (Clone)
Monoclonal ()
Western Blotting (WB)
Pubmed 2 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 0.1 mg
Shipping to United States ( )
Brand BD Pharmingen™
Immunogen Coxpox CrmA (full-length) Recombinant Protein
Clone A71-1
Isotype IgG1, kappa
Characteristics 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
Purification The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
Alternative Name CrmA
Background CrmA (cytokine response modifier A) is a cowpox virus-encoded serpin protein that inhibits apoptosis in a variety of systems. CrmA protects cells against apoptosis by inhibiting specific members of the ICE/CED-3 cysteine protease (designated caspase) family that are essential for apoptosis. One of the proteases inhibited by CrmA is caspase-3 (also known as CPP32, Yama, apopain). Caspase-3 is activated early in apoptosis and appears to be involved in the proteolysis of several important molecules. Activated caspase-3 is found only in cells undergoing apoptosis, and consists of 17 and 11 kDa subunits that are derived from a 32 kDa proenzyme (pro-caspase-3) by cleavage at multiple aspartic acid sites. Poly (ADP-ribose) polymerase (PARP) is a protein cleaved by activated caspase-3 during apoptosis. CrmA inhibits PARP cleavage, thereby blocking apoptosis. It is thought that if a particular apoptotic pathway can be inhibited by CrmA, then the activation of a caspase is necessary for apoptosis to take place. For example, CrmA has been shown to block Fas-mediated apoptosis, suggesting that activation of one or more caspases is required for Fas-induced cell death.
Synonyms: Cytokine Response Modifier A
Molecular Weight 38 kDa

Related Products: ABIN967389

Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer Aqueous buffered solution containing ≤0.09 % sodium azide.
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store undiluted at 4° C.
Supplier Images
Western Blotting (WB) image for anti-CrmA Or CPXV207 Protein antibody (ABIN967526) Western blot analysis of recombinant CrmA. Lane 1: 0.5 µg of full-length recombinant ...
Image no. 2 for anti-CrmA Or CPXV207 Protein antibody (ABIN967526) anti-CrmA Or CPXV207 Protein antibody (Image 2)
Product cited in: Juo, Kuo, Reynolds et al.: "Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases." in: Molecular and cellular biology, Vol. 17, Issue 1, pp. 24-35, 1997 (PubMed).

Komiyama, Quan, Salvesen: "Inhibition of cysteine and serine proteinases by the cowpox virus serpin CRMA." in: Advances in experimental medicine and biology, Vol. 389, pp. 173-6, 1997 (PubMed).

Catalog No. ABIN967526
Contact our Customer Service for availability and price in your country.

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)